N-Power Medicine is building the first always-on clinical research system in community oncology, with the aim of boosting clinical trial participation and accelerating drug development. The company, founded in 2021, operates within the healthcare and clinical research sectors, applying AI and technology to its platform. In 2025, N-Power Medicine acquired Syapse, expanding its network to become one of the largest community-based prospective clinical research networks.
The company has raised over $85 million in funding. It is staffed by an interdisciplinary team with expertise across healthcare, engineering, technology, and regulatory affairs. N-Power Medicine states its core values are generosity, curiosity, and humility.
